CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
ACRYSOF® Single-Piece NATURAL Toric IOL Model SN60T9 and Model SN60T8.device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00967473
NCT00967473N/ACompleted
CompareCT.gov

ACRYSOF® Toric NATURAL T9 Intraocular Lens (IOL)

Alcon Research·interventional·Posted Aug 27, 2009·Updated Jan 9, 2017

In Brief

A clinical study evaluating ACRYSOF® Single-Piece NATURAL Toric IOL Model SN60T9 and Model SN60T8. for Bilateral Cataract. Completed, enrolled 15 participants across 1 site.

Detailed Summary

The purpose of this study is to describe rates of spatial distortions related to intraocular lens (IOL) misalignment for ACRYSOF® Single-Piece Toric NATURAL IOL Model SN60T9 when implanted bilaterally into the capsular bag following phacoemulsification in adult patients with bilateral cataract and regular corneal astigmatism. Subjects were implanted with the Model SN60T9 in the first operative (study) eye and either Model SN60T9 or Model SN60T8 in the second operative eye.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBilateral Cataract
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedAug 27, 2009
Enrollment StartAug 1, 2009
Primary CompletionMay 1, 2010
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 16.8 years ago

Interventions

ACRYSOF® Single-Piece NATURAL Toric IOL Model SN60T9 and Model SN60T8.device

ACRYSOF® Single-Piece Toric NATURAL Intraocular Lens (IOL) Model SN60T9 in the first eye and either the ACRYSOF® Single-Piece Toric NATURAL IOL Model SN60T9 or Model SN60T8 in the second eye.